0001181431-13-020614.txt : 20130403
0001181431-13-020614.hdr.sgml : 20130403
20130403165400
ACCESSION NUMBER: 0001181431-13-020614
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130401
FILED AS OF DATE: 20130403
DATE AS OF CHANGE: 20130403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fleming Michael O.
CENTRAL INDEX KEY: 0001475320
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24260
FILM NUMBER: 13740192
MAIL ADDRESS:
STREET 1: 5959 S. SHERWOOD FOREST BLVD.
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMEDISYS INC
CENTRAL INDEX KEY: 0000896262
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
IRS NUMBER: 113131700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5959 S SHERWOOD FOREST BLVD
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
BUSINESS PHONE: 2252922031
MAIL ADDRESS:
STREET 1: 5959 S SHERWOOD FOREST BLVD
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
FORMER COMPANY:
FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP
DATE OF NAME CHANGE: 19940819
FORMER COMPANY:
FORMER CONFORMED NAME: M&N CAPITAL CORP
DATE OF NAME CHANGE: 19930125
4
1
rrd376012.xml
X0306
4
2013-04-01
0
0000896262
AMEDISYS INC
AMED
0001475320
Fleming Michael O.
5959 S. SHERWOOD FOREST BLVD.
BATON ROUGE
LA
70816
0
1
0
0
Chief Medical Officer
Common Stock
2013-04-01
4
A
0
6501
0
A
18349
D
Common Stock
2013-04-01
4
F
0
832
10.96
D
17517
D
Common Stock
679
I
Through 401(k) Plan
Restricted Stock Unit
2013-04-01
4
A
0
6501
0
A
2018-04-01
Common Stock
6501
6501
D
The shares awarded are subject to service-based vesting conditions and will vest in equal, one-third increments on each of April 1, 2014, April 1, 2015 and April 1, 2016, provided that the reporting person remains employed by the issuer on each such date.
Includes 282 shares acquired by the reporting person under the Amedisys, Inc. 401(k) Plan since the date of the reporting person's last report.
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Amedisys, Inc. (the "Company") common stock with vesting conditions based on the Company's compound total shareholder return (TSR) over defined measurement periods. The number of shares of Company common stock earned upon vesting of the RSUs will (i) depend on (a) the actual compound TSR achieved and (b) the applicable measurement period and (ii) will range from 17% to 160% of the number of RSUs reported in Column 5 of Table II, assuming the reporting person remains continuously employed by the Company through the vesting date.
Celeste R. Peiffer on behalf of Michael O. Fleming pursuant to a Power of Attorney
2013-04-03